Research Briefings

Blossom has joined forces with Report on Psychedelics to produce a bi-weekly briefing on psychedelic research. Each briefing recaps the latest psychedelic research in easy to understand language. The briefings aim to help grow the impact of psychedelic research and accurately represent findings to a wider audience.

In the Research Briefing 1) a closer look at psychedelics as a tool to explore the depths of consciousness, 2) using psychedelics to explore creativity, a look at the brainwaves, 3) predicting & maximising the mystical experience.
In the Research Briefing of March 15th: 1) LSD safe to give in a novel, cost-effective, therapeutic framework, 2) Can you distinguish LSD from psilocybin, a new study says no, 3) The challenges ahead for psychedelics as medicine
In the Research Briefing of February 14th: 1) Flashbacks are common in psychedelic research but participants don't seem to mind 2) LSD influences creativity, breaking down thought patterns and relocating them toward the new 3) Psychedelics and society; thought on the past, present and future
In the Research Briefing of January 24th: 1) Ketamine effective in abstaining from alcohol for up to 6 months later 2) Real-world data provides further evidence ketamine therapy is effective for depression 3) But a large study finds ketamine not to be effective for PTSD in service members
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
In the Research Briefing of December 20th: 1) New double-blind study doesn't find benefits of microdosing 2) The negative post-acute effects of MDMA appear to be absent in the clinical setting
In the Research Briefing of December 6th: 1) The methodological challenges faced in psychedelic clinical trials (and how to fix them) 2) Mystical experiences in recreational use associated with improvements in wellbeing 3) A novel 5-MeO-DMT formulation proves to be safe in Phase I trial
In the Research Briefing of November 22nd: 1) Those who microdose report lower anxiety & depression 2) Psilocybin therapy increases cognitive and neural flexibility 3) How can psilocybin help decrease craving in alcoholism
In the Research Briefing of November 8th: 1) To patent or not to patent psychedelics 2) Getting psychedelics to a community clinic near you 3) The influence of cannabis on psychedelic experiences
In the Research Briefing of October 25th: 1) A summary of what we know about 5-MeO-DMT 2) Investigating ketamine's chemical structure for safety and efficacy 3) Testing how LSD works in the brain by modelling the effects in a whole-brain simulation

Research Briefings

Blossom has joined forces with Report on Psychedelics to produce a bi-weekly briefing on psychedelic research. Each briefing recaps the latest psychedelic research in easy to understand language. The briefings help you make sense of the latest psychedelic research through explanation and adding context to research papers.

Recent briefings are also accompanied by an audio recording that is released on the podcast channel of Report on Psychedelics.

Understand the latest psychedelic research with our bi-weekly research briefing.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account